List of Amylin Pharmaceuticals patents

Patents where

Current Assignee

Name

Amylin Pharmaceuticals

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7482425 Compositions for lipid matrix-assisted chemical ligation	Patent 7482425 was granted and assigned to Amylin Pharmaceuticals on January, 2009 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	7482425	January 27, 2009
‌ US Patent 7928065 Methods of treatment using exendin peptides or GLP-1 peptides	Patent 7928065 was granted and assigned to Amylin Pharmaceuticals on April, 2011 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	7928065	April 19, 2011
‌ US Patent 7442680 Inotropic and diuretic effects of GLP-1 and GLP-1 agonists	Patent 7442680 was granted and assigned to Amylin Pharmaceuticals on October, 2008 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	7442680	October 28, 2008
‌ US Patent 7153825 Methods for glucagon suppression using modified exendins	Patent 7153825 was granted and assigned to Amylin Pharmaceuticals on December, 2006 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	7153825	December 26, 2006
‌ US Patent 7115569 Exendins, exendin agonists, and methods for their use	Patent 7115569 was granted and assigned to Amylin Pharmaceuticals on October, 2006 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	7115569	October 3, 2006
‌ US Patent 7419952 Use of exendins and agonists thereof to treat diabetes	Patent 7419952 was granted and assigned to Amylin Pharmaceuticals on September, 2008 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	7419952	September 2, 2008
‌ US Patent 6956026 Use of exendins for the reduction of food intake	Patent 6956026 was granted and assigned to Amylin Pharmaceuticals on October, 2005 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	6956026	October 18, 2005
‌ US Patent 6989366 Exendins, exendin agonists, and methods for their use	Patent 6989366 was granted and assigned to Amylin Pharmaceuticals on January, 2006 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	6989366	January 24, 2006
‌ US Patent 7297761 Pharmaceutical compositions containing exendins	Patent 7297761 was granted and assigned to Amylin Pharmaceuticals on November, 2007 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	7297761	November 20, 2007
‌ US Patent 7566697 Carboxy protection strategies for acidic C-terminal amino acids in chemical ligation of oligopeptides	Patent 7566697 was granted and assigned to Amylin Pharmaceuticals on July, 2009 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	7566697	July 28, 2009
‌ US Patent 7741269 Exendins and exendin agonists for weight reduction and obesity	Patent 7741269 was granted and assigned to Amylin Pharmaceuticals on June, 2010 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	7741269	June 22, 2010
‌ US Patent 7700549 Exendin agonist analogs to treat diabetes	Patent 7700549 was granted and assigned to Amylin Pharmaceuticals on April, 2010 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	7700549	April 20, 2010
‌ US Patent 6858576 Methods for regulating gastrointestinal motility	Patent 6858576 was granted and assigned to Amylin Pharmaceuticals on February, 2005 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	6858576	February 22, 2005
‌ US Patent 7691963 Exendins and exendin agonists modified with polyamino acids	Patent 7691963 was granted and assigned to Amylin Pharmaceuticals on April, 2010 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	7691963	April 6, 2010
‌ US Patent 7521423 Exendin pharmaceutical compositions	Patent 7521423 was granted and assigned to Amylin Pharmaceuticals on April, 2009 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	7521423	April 21, 2009
‌ US Patent 6924264 Modified exendins and exendin agonists	Patent 6924264 was granted and assigned to Amylin Pharmaceuticals on August, 2005 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	6924264	August 2, 2005
‌ US Patent 6872700 Methods for glucagon suppression	Patent 6872700 was granted and assigned to Amylin Pharmaceuticals on March, 2005 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	6872700	March 29, 2005
‌ US Patent 8076288 Hybrid polypeptides having glucose lowering activity	Patent 8076288 was granted and assigned to Amylin Pharmaceuticals on December, 2011 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	8076288	December 13, 2011
‌ US Patent 7118737 Polymer-modified synthetic proteins	Patent 7118737 was granted and assigned to Amylin Pharmaceuticals on October, 2006 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	7118737	October 10, 2006
‌ US Patent 6998387 Human appetite control by glucagon-like peptide receptor binding compounds	Patent 6998387 was granted and assigned to Amylin Pharmaceuticals on February, 2006 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	6998387	February 14, 2006
‌ US Patent 7608692 Exendins and exendin agonists modified with albumin	Patent 7608692 was granted and assigned to Amylin Pharmaceuticals on October, 2009 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	7608692	October 27, 2009
‌ US Patent 7129327 Polypeptide and protein derivatives and process for their preparation	Patent 7129327 was granted and assigned to Amylin Pharmaceuticals on October, 2006 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	7129327	October 31, 2006
‌ US Patent 8026210 Exendins and exendin agonist analogs to regulate gastrointestinal motility	Patent 8026210 was granted and assigned to Amylin Pharmaceuticals on September, 2011 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	8026210	September 27, 2011
‌ US Patent 8057822 Modified exendins and exendin agonists	Patent 8057822 was granted and assigned to Amylin Pharmaceuticals on November, 2011 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	8057822	November 15, 2011
‌ US Patent 7407934 Methods for regulating postprandial blood glucose	Patent 7407934 was granted and assigned to Amylin Pharmaceuticals on August, 2008 by the United States Patent and Trademark Office.	Amylin Pharmaceuticals	United States Patent and Trademark Office	7407934	August 5, 2008

Results per page:

81 results

0 selected

81 results

0 selected